血液透析所致心血管疾病。
Hemodialysis-induced cardiovascular disease.
作者信息
Ahmadmehrabi Shadi, Tang W H Wilson
机构信息
Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, USA.
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.
出版信息
Semin Dial. 2018 May;31(3):258-267. doi: 10.1111/sdi.12694. Epub 2018 Apr 6.
Abstract
More than half of all deaths among end stage renal disease (ESRD) patients are due to cardiovascular disease (CVD). Cardiovascular changes secondary to renal dysfunction, including fluid overload, uremic cardiomyopathy, secondary hyperparathyroidism, anemia, altered lipid metabolism, and accumulation of gut microbiota-derived uremic toxins like trimethylamine N-oxidase, contribute to the high risk for CVD in the ESRD population. In addition, conventional hemodialysis (HD) itself poses myocardial stress and injury on the already compromised cardiovascular system in uremic patients. This review will provide an overview of cardiovascular changes in chronic kidney disease and ESRD, a description of reported mechanisms for HD-induced myocardial injury, comparison of HD with other treatment modalities in the context of CVD, and possible management strategies.
摘要
终末期肾病（ESRD）患者中超过一半的死亡是由心血管疾病（CVD）所致。继发于肾功能不全的心血管变化，包括液体超负荷、尿毒症心肌病、继发性甲状旁腺功能亢进、贫血、脂质代谢改变以及肠道微生物群衍生的尿毒症毒素（如三甲胺N-氧化物）的蓄积，导致ESRD人群发生CVD的风险很高。此外，传统血液透析（HD）本身会给已经受损的尿毒症患者心血管系统带来心肌应激和损伤。本综述将概述慢性肾脏病和ESRD中的心血管变化，描述已报道的HD诱导心肌损伤的机制，比较HD与其他治疗方式在CVD背景下的情况，以及可能的管理策略。
相似文献
1
Hemodialysis-induced cardiovascular disease.血液透析所致心血管疾病。
Semin Dial. 2018 May;31(3):258-267. doi: 10.1111/sdi.12694. Epub 2018 Apr 6.
2
Cardiovascular complications in end-stage renal disease and hemodialysis patients.终末期肾病和血液透析患者的心血管并发症
Acta Med Croatica. 1996;50(4-5):199-208.
3
Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.强化血液透析、左心室肥厚与心血管疾病。
Am J Kidney Dis. 2016 Nov;68(5S1):S5-S14. doi: 10.1053/j.ajkd.2016.05.025.
4
5
Cardiovascular disease in dialysis patients.透析患者的心血管疾病。
Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii28-iii34. doi: 10.1093/ndt/gfy174.
6
Optimal dialysis for the end-stage renal disease patient with cardiovascular disease.终末期肾病合并心血管疾病患者的优化透析
Adv Chronic Kidney Dis. 2004 Jul;11(3):261-73. doi: 10.1053/j.arrt.2004.04.004.
7
Peritoneal dialysis has optimal intradialytic hemodynamics and preserves residual renal function: Why isn't it better than hemodialysis?腹膜透析具有最佳的透析内血流动力学，并能保留残余肾功能：为什么它不比血液透析更好？
Semin Dial. 2019 Jan;32(1):3-8. doi: 10.1111/sdi.12752. Epub 2018 Oct 23.
8
Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.慢性肾脏病患者单次血液透析过程中炎症和氧化应激标志物的变化。
Ren Fail. 2018 Nov;40(1):534-540. doi: 10.1080/0886022X.2018.1487857.
9
oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients.氧化型低密度脂蛋白——将血液高凝性与血液透析的尿毒症患者心血管疾病的存在联系起来的分子。
Thromb Res. 2014 Sep;134(3):711-6. doi: 10.1016/j.thromres.2014.07.007. Epub 2014 Jul 16.
10
Inadequate treatment of cardiovascular disease and cardiovascular disease risk factors in dialysis patients: a commentary.透析患者心血管疾病及心血管疾病危险因素的治疗不足：一篇评论
Semin Dial. 2004 Sep-Oct;17(5):342-5. doi: 10.1111/j.0894-0959.2004.17360.x.
引用本文的文献
1
Quality of life in older immigrant adults on hemodialysis.老年移民血液透析患者的生活质量
PLoS One. 2025 Sep 5;20(9):e0322426. doi: 10.1371/journal.pone.0322426. eCollection 2025.
2
Pancreaticoduodenectomy in a Hemodialysis Patient: First Report From Kazakhstan with a Brief Literature Review.一名血液透析患者的胰十二指肠切除术：哈萨克斯坦的首例报告及文献简要综述
Int Med Case Rep J. 2025 Aug 22;18:1077-1083. doi: 10.2147/IMCRJ.S538133. eCollection 2025.
3
Kynurenine Promotes Phosphate-Induced Endothelial Calcification via Endothelial-to-Mesenchymal Transition, Osteoblastic Differentiation and AhR Activation.犬尿氨酸通过内皮-间充质转化、成骨细胞分化和芳烃受体激活促进磷酸盐诱导的内皮钙化。
Toxins (Basel). 2025 Aug 19;17(8):421. doi: 10.3390/toxins17080421.
4
Renal and Cardiovascular Outcomes of IABP-Assisted PCI in Renal Dysfunction: A Propensity-Matched Study and MACEs Prediction Model Development.肾功能不全患者中主动脉内球囊反搏辅助经皮冠状动脉介入治疗的肾脏和心血管结局：一项倾向匹配研究及主要不良心血管事件预测模型的开发
Int J Gen Med. 2025 Aug 18;18:4549-4562. doi: 10.2147/IJGM.S532170. eCollection 2025.
5
Perioperative and mid-term prognosis in coronary artery bypass grafting patients with mild renal dysfunction.轻度肾功能不全的冠状动脉搭桥术患者的围手术期及中期预后
Ren Fail. 2025 Dec;47(1):2539944. doi: 10.1080/0886022X.2025.2539944. Epub 2025 Aug 7.
6
Cardiac Indices Parameters on the Ultrasonic Cardiac Output Monitor as Potential Indicators to Predict the Ultrafiltration Endpoint Success in Acute Heart Failure Treatment.超声心输出量监测仪上的心脏指数参数作为预测急性心力衰竭治疗中超滤终点成功的潜在指标。
Rev Cardiovasc Med. 2025 May 22;26(5):27100. doi: 10.31083/RCM27100. eCollection 2025 May.
7
Correlation of tongue coating thickness with microinflammatory state and oral microbiome in maintenance hemodialysis patients.维持性血液透析患者舌苔厚度与微炎症状态及口腔微生物群的相关性
J Oral Microbiol. 2025 May 5;17(1):2488054. doi: 10.1080/20002297.2025.2488054. eCollection 2025.
8
Understanding uremic cardiomyopathy: from pathogenesis to diagnosis and the horizon of therapeutic innovations.了解尿毒症心肌病：从发病机制到诊断以及治疗创新的前景
PeerJ. 2025 Mar 31;13:e18978. doi: 10.7717/peerj.18978. eCollection 2025.
9
Frailty Associated with Cardiovascular Mortality in Hemodialysis Patients.血液透析患者中与心血管死亡率相关的衰弱
Acta Cardiol Sin. 2025 Mar;41(2):219-229. doi: 10.6515/ACS.202503_41(2).20241111B.
10
Predicting 3-year all-cause mortality in patients undergoing hemodialysis using machine learning.使用机器学习预测接受血液透析患者的3年全因死亡率。
J Nephrol. 2025 Mar 6. doi: 10.1007/s40620-025-02236-2.
本文引用的文献
1
Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.HEMO 研究的结果表明，对甲酚硫酸盐和吲哚硫酸酯与心血管结局无关。
Kidney Int. 2017 Dec;92(6):1484-1492. doi: 10.1016/j.kint.2017.05.012. Epub 2017 Jul 21.
2
The relation between hemoglobin variability and carotid intima-media thickness in chronic hemodialysis patients.慢性血液透析患者血红蛋白变异性与颈动脉内膜中层厚度之间的关系。
Int Urol Nephrol. 2017 Oct;49(10):1859-1866. doi: 10.1007/s11255-017-1651-6. Epub 2017 Jul 15.
3
The Potential Cardiovascular Benefits of Low-Glucose Degradation Product, Biocompatible Peritoneal Dialysis Fluids: A Review of the Literature.低葡萄糖降解产物生物相容性腹膜透析液对心血管系统的潜在益处：文献综述
Perit Dial Int. 2017 Jul-Aug;37(4):375-383. doi: 10.3747/pdi.2016.00228.
4
Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对透析患者心血管事件及残余肾功能的影响：一项随机对照试验的荟萃分析
BMC Nephrol. 2017 Jun 30;18(1):206. doi: 10.1186/s12882-017-0605-7.
5
Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.肠道微生物群代谢产物与主要不良心血管疾病事件及死亡风险：前瞻性研究的系统评价和荟萃分析
J Am Heart Assoc. 2017 Jun 29;6(7):e004947. doi: 10.1161/JAHA.116.004947.
6
Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients.仍是一个合理的目标：针对透析患者和晚期慢性肾病患者的胆固醇治疗
Semin Dial. 2017 Sep;30(5):390-394. doi: 10.1111/sdi.12621. Epub 2017 Jun 19.
7
Antithrombotic therapy in end-stage renal disease.终末期肾病的抗栓治疗
Hemodial Int. 2017 Oct;21(4):453-471. doi: 10.1111/hdi.12571. Epub 2017 May 23.
8
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.对称二甲基精氨酸、高密度脂蛋白与心血管疾病。
Eur Heart J. 2017 May 21;38(20):1597-1607. doi: 10.1093/eurheartj/ehx118.
9
Time- and dose dependent actions of cardiotonic steroids on transcriptome and intracellular content of Na and K: a comparative analysis.时间和剂量依赖性作用的强心甾体对转录组和细胞内的钠和钾含量：比较分析。
Sci Rep. 2017 Mar 27;7:45403. doi: 10.1038/srep45403.
10
Risk factors for mortality in patients undergoing hemodialysis: A systematic review and meta-analysis.接受血液透析患者的死亡风险因素：一项系统评价和荟萃分析。
Int J Cardiol. 2017 Jul 1;238:151-158. doi: 10.1016/j.ijcard.2017.02.095. Epub 2017 Feb 22.
Zotero 插件